Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This is a 6-week comparison of asenapine versus placebo as an add-on to ongoing
antidepressant treatment in patients with major depression who have not had a complete
therapeutic response to treatment with the antidepressant alone.
The investigators hypothesize that added asenapine will produce greater reductions in
depression than will added placebo.